Updates on Opioid Pharmacology – Implications for Research and Clinical Practice
May 29, 2013 12 pm - 1 pm ET
Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
A webinar offered by American Osteopathic Academy of Addiction Medicine (AOAAM).
About the Webinar:
Opioid agonists such as morphine and hydrocodone remain a mainstay for treating moderate to severe chronic pain. Their use is not without controversy and debate, primarily around side effects including abuse liability and diversion. Their use is further limited by other side effects including opioid induced bowel dysfunction, nausea and vomiting, and pruritus that can impact patient compliance and satisfaction with therapy. This webinar will provide an update on the pharmacology of the drug class, new insights into acute and chronic effects, strategies to reduce some of the side effects, and recommendations for future studies. Several case studies will also be presented to help illustrate the challenges and opportunities with opioid analgesics.
Date: May 29, 2013
Speaker: Edward Bilsky, Ph.D.
Time: 12:00 pm – 1:00 pm ET
To Register: http://events.constantcontact.com/register/event?llr=c9shxsbab&oeidk=a07e7dyjdll8469aa43
Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reﬂect the ofﬁcial policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.